TURKISH JOURNAL OF HEMATOLOGY

More documents

Recommendations

Info

Full instructions and support are available on the site, and a user IDand password can be obtained during your first visit. Full support forauthors is provided. Each page has a “Get Help Now” icon that connectsdirectly to the online support system. Contact the journal administratorwith any questions about submitting your manuscript to the journal(info@tjh.com.tr). For ScholarOne Manuscripts customer support, clickon the “Get Help Now” link on the top right-hand corner of every pageon the site.The Electronic Submission ProcessLog in to your author center. Once you have logged in, click the “Submita Manuscript” link in the menu bar. Enter the appropriate data andanswer the questions. You may copy and paste directly from yourmanuscript. Click the “Next” button on each screen to save your workand advance to the next screen.Upload FilesClick on the “Browse” button and locate the file on your computer. Selectthe appropriate designation for each file in the drop-down menu next tothe “Browse” button. When you have selected all the files you want toupload, click the “Upload Files” button. Review your submission beforesending to the journal. Click the “Submit” button when you are finishedreviewing. You can use ScholarOne Manuscripts at any time to checkthe status of your submission. The journal’s editorial office will informyou by e-mail once a decision has been made. After your manuscripthas been submitted, a checklist will then be completed by the EditorialAssistant. The Editorial Assistant will check that the manuscript containsall required components and adheres to the author guidelines. Once theEditorial Assistant is satisfied with the manuscript it will be forwarded tothe Senior Editor, who will assign an editor and reviewers.The Review ProcesssEach manuscript submitted to The Turkish Journal of Hematology issubject to an initial review by the editorial office in order to determineif it is aligned with the journal’s aims and scope and complies withessential requirements. Manuscripts sent for peer review will be assignedto one of the journal’s associate editors that has expertise relevant to themanuscript’s content. All accepted manuscripts are sent to a statisticaland English language editor before publishing. Once papers have beenreviewed, the reviewers’ comments are sent to the Editor, who will thenmake a preliminary decision on the paper. At this stage, based on thefeedback from reviewers, manuscripts can be accepted or rejected, orrevisions can be recommended. Following initial peer-review, articlesjudged worthy of further consideration often require revision. Revisedmanuscripts generally must be received within 3 months of the date ofthe initial decision. Extensions must be requested from the AssociateEditor at least 2 weeks before the 3-month revision deadline expires;The Turkish Journal of Hematology will reject manuscripts that arenot received within the 3-month revision deadline. Manuscripts withextensive revision recommendations will be sent for further review(usually by the same reviewers) upon their re-submission. When amanuscript is finally accepted for publication, the Technical Editorundertakes a final edit and a marked-up copy will be e-mailed to thecorresponding author for review and any final adjustments.Submission of Revised PapersWhen revising a manuscript based on the reviewers’ and Editor’sfeedback, please insert all changed text in red. Please do not usetrack changes, as this feature can make reading difficult. To submitrevised manuscripts, please log in to your author center at ScholarOneManuscripts. Your manuscript will be stored under “Manuscripts withDecisions”. Please click on the “Create a Revision” link located to the rightof the manuscript title. A revised manuscript number will be created foryou; you will then need to click on the “Continue Submission” button.You will then be guided through a submission process very similar tothat for new manuscripts. You will be able to amend any details youwish. At stage 6 (“File Upload”), please delete the file for your originalmanuscript and upload the revised version. Additionally, please uploadan anonymous cover letter, preferably in table format, including apoint-by-point response to the reviews’ revision recommendations. Youwill then need to review your paper as a PDF and click the “Submit”button. Your revised manuscript will have the same ID number as theoriginal version, but with the addition of an R and a number at theend, for example, TJH-2011-0001 for an original and TJH-2011-0001.R1, indicating a first revision; subsequent revisions will end with R2,R3, and so on. Please do not submit a revised manuscript as a newpaper, as revised manuscripts are processed differently. If you click onthe “Create a Revision” button and receive a message stating that therevision option has expired, please contact the Editorial Assistant atinfo@tjh.com.tr to reactivate the option.English Language and Statistical EditingAll manuscripts are professionally edited by an English language editorprior to publication. After papers have been accepted for publication,manuscript files are forwarded to the statistical and English languageeditors before publishing. Editors will make changes to the manuscriptto ensure it adheres to TJH requirements. Significant changes orconcerns are referred to corresponding authors for editing.Online EarlyThe Turkish Journal of Hematology publishes abstracts of acceptedmanuscripts online in advance of their publication. Once an acceptedmanuscript has been edited, the authors have submitted any finalcorrections, and all changes have been incorporated, the manuscript willbe published online. At that time the manuscript will receive a DigitalObject Identifier (DOI) number. Both forms can be found at www.tjh.com.tr. Authors of accepted manuscripts will receive electronic pageproofs directly from the printer and are responsible for proofreadingand checking the entire manuscript, including tables, figures, andreferences. Page proofs must be returned within 48 hours to avoid delaysin publication.A-VIII
CONTENTSResearch Articles77 In Silico Study of Correlation between Missense Variations of F8 Gene and Inhibitor Formation in Severe Hemophilia AMostefa Fodil, Faouzia Zemani; Oran, Algeria84 Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible PrognosticFactor - A Multicenter Cohort StudyMüfide Okay, Tuncay Aslan, Evren Özdemir, Ayşegül Üner, Arzu Sağlam, Elif Güngör, Ayşe Uysal, Nevin Alayvaz Aslan, Esra Yıldızhan, AbdullahAğıt, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroğlu, Serdar Sivgin, Gülsüm Akgün Çağlıyan, Sinan Demircioğlu, İbrahim Barışta,Esra Özhamam, Filiz Vural, Bülent Eser, Gülsüm Özet, Rahşan Yıldırım, Mehmet Hilmi Doğu, İlhami Berber, Mehmet Ali Erkurt, Ümit YavuzMalkan, Fevzi Altuntaş, Yahya Büyükaşık; Ankara, Edirne, Trabzon, Samsun, Kayseri, İzmir, Denizli, Van, Erzurum, İstanbul, Malatya, Turkey91 Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective CohortStudyHuijuan Wang, Huixing Zhou, Zhiyao Zhang, Chuanying Geng, Wenming Chen; Beijing, China98 PTEN and AKT1 Variations in Childhood T-Cell Acute Lymphoblastic LeukemiaFulya Küçükcankurt, Yücel Erbilgin, Sinem Fırtına, Özden Hatırnaz Ng, Zeynep Karakaş, Tiraje Celkan, Ayşegül Ünüvar, Uğur Özbek, MügeSayitoğlu; İstanbul, Turkey104 Expression Profile Screening and Bioinformatics Analysis of circRNA, LncRNA, and mRNA in Acute Myeloid Leukemia Drug-Resistant CellsMeiling Li, Fuxue Meng, Quanyi Lu; Xiamen, Duyun, ChinaPerspectives in Hematology111 Endocrine and Metabolic Disorders after Hematopoietic Cell TransplantationAnnalisa Paviglianiti; Paris, FranceBrief Report116 The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with AcuteMyeloid LeukemiaRafiye Çiftçiler, İbrahim C. Haznedaroğlu, Nilgün Sayınalp, Osman Özcebe, Salih Aksu, Haluk Demiroğlu, Hakan Göker, Ümit Yavuz Malkan,Yahya Büyükaşık; Ankara, TurkeyImages in Hematology121 A Rare Chromosomal Abnormality in Chronic Lymphocytic Leukemia: t(13;13)Akbar Safaei, Ahmad Monabati, Moeinadin Safavi; Shiraz, Tehran, Iran123 Garland of Erythroblasts around a Macrophage: Erythroblastic IslandChandan Kumar, Garima Jain, Anita Chopra; New Delhi, IndiaA-IX
Page 1: Volume 37 Issue 2June 2020E-ISSN: 1
Page 4 and 5: Contact InformationEditorial Corres
Page 6 and 7: TURKISH JOURNAL OF HEMATOLOGYINSTRU
Page 8 and 9: important findings should be highli
Page 12 and 13: Letters to the Editor125 Percentage
Page 14 and 15: Fodil M and Zemani F: Inhibitor Dev
Page 20 and 21: RESEARCH ARTICLEDOI: 10.4274/tjh.ga
Page 22 and 23: Okay M, et al: Splenic Marginal Zon
Page 28 and 29: Wang H, et al: Bortezomib-based Reg
Page 36 and 37: Küçükcankurt F, et al: PTEN and
Page 38 and 39: Küçükcankurt F, et al: PTEN and
Page 42 and 43: Li M, et al: Expression Profile of
Page 48 and 49: Paviglianiti A: Metabolic Diseases
Page 50 and 51: Paviglianiti A: Metabolic Diseases
Page 52 and 53: BRIEF REPORTDOI: 10.4274/tjh.galeno
Page 54 and 55: Çiftçiler R, et al: The Impact of
Page 56 and 57: Çiftçiler R, et al: The Impact of
Page 58 and 59: Safaei A, et al: Rare Chromosomal A
Page 60 and 61:
Kumar C, et al: Erythroblastic Isla
Page 62 and 63:
LETTERS TO THE EDITORTurk J Hematol
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
show all

TURKISH JOURNAL OF HEMATOLOGY

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?